Insider Transaction: The Boston Beer Company, Inc. (SAM)’s Vice President – Legal Tara Heath Unloaded 64 shares; Wellington Management Group Llp Trimmed Allscripts Healthcare Solutn (MDRX) Holding

Wellington Management Group Llp decreased Allscripts Healthcare Solutn (MDRX) stake by 1.43% reported in 2017Q3 SEC filing. Wellington Management Group Llp sold 285,914 shares as Allscripts Healthcare Solutn (MDRX)’s stock declined 3.95%. The Wellington Management Group Llp holds 19.66M shares with $279.78M value, down from 19.95M last quarter. Allscripts Healthcare Solutn now has $2.74B valuation. The stock increased 0.43% or $0.065 during the last trading session, reaching $15.175. About 624,514 shares traded. Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) has declined 8.32% since January 4, 2017 and is downtrending. It has underperformed by 25.02% the S&P500.

Boston Beer Co Inc Vice President – Legal and an insider Tara Heath recently made a sale of 64 company shares with a total value of $12,090 at the avg market share price which was $188.9. Today, Tara Heath holds 1,663 shares or roughly 0.01% of the company’s total market capitalization. A filing documented published January 03, 2018 with the (SEC), made public here, shows the complete information of the deal.

The Boston Beer Company, Inc. produces and sells alcohol beverages primarily in the United States. The company has market cap of $2.18 billion. The Company’s flagship beer is Samuel Adams Boston Lager. It has a 25.72 P/E ratio. The firm sells approximately 60 beers under the Samuel Adams and the Sam Adams brands; 20 hard cider beverages under the Angry Orchard brand; 13 flavored malt beverages under the Twisted Tea brand; and 4 hard seltzer beverages under the Truly Spiked & Sparkling brand name, as well as approximately 40 beers under A&S Brewing trade name.

Since October 31, 2017, it had 0 buys, and 2 insider sales for $262,214 activity. 1,000 The Boston Beer Company, Inc. (NYSE:SAM) shares with value of $186,750 were sold by Grinnell David L.. 439 shares valued at $75,464 were sold by POTTER JONATHAN N. on Tuesday, October 31.

Investors sentiment decreased to 1.15 in 2017 Q3. Its down 0.04, from 1.19 in 2017Q2. It is negative, as 19 investors sold The Boston Beer Company, Inc. shares while 69 reduced holdings. 43 funds opened positions while 58 raised stakes. 8.75 million shares or 3.77% more from 8.43 million shares in 2017Q2 were reported. Smith Graham And Inv Ltd Partnership accumulated 54,108 shares. Citigroup accumulated 2,577 shares. Wells Fargo & Communication Mn has invested 0% in The Boston Beer Company, Inc. (NYSE:SAM). Tiaa Cref Inv Management Limited Com holds 0% in The Boston Beer Company, Inc. (NYSE:SAM) or 33,854 shares. Raymond James And Assoc has 0% invested in The Boston Beer Company, Inc. (NYSE:SAM). Ameritas Investment Prtnrs reported 3,491 shares. Eqis Capital Management has invested 0.01% in The Boston Beer Company, Inc. (NYSE:SAM). 2,065 were reported by Cim Investment Mangement. Wellington Management Group Incorporated Llp stated it has 0% of its portfolio in The Boston Beer Company, Inc. (NYSE:SAM). Vgi Prtn Pty Ltd invested 7.25% in The Boston Beer Company, Inc. (NYSE:SAM). Putnam Fl Investment Management accumulated 1,372 shares. Ohio-based Huntington Commercial Bank has invested 0% in The Boston Beer Company, Inc. (NYSE:SAM). Legal & General Grp Public Limited reported 7,847 shares or 0% of all its holdings. 210,000 are owned by Manikay Prtnrs Llc. Chilton Investment Co Llc holds 0.02% of its portfolio in The Boston Beer Company, Inc. (NYSE:SAM) for 3,157 shares.

Analysts await The Boston Beer Company, Inc. (NYSE:SAM) to report earnings on February, 28. They expect $0.94 earnings per share, down 46.29% or $0.81 from last year’s $1.75 per share. SAM’s profit will be $10.93 million for 49.83 P/E if the $0.94 EPS becomes a reality. After $2.78 actual earnings per share reported by The Boston Beer Company, Inc. for the previous quarter, Wall Street now forecasts -66.19% negative EPS growth.

The stock increased 0.21% or $0.4 during the last trading session, reaching $187.35. About 52,024 shares traded. The Boston Beer Company, Inc. (NYSE:SAM) has declined 3.11% since January 4, 2017 and is downtrending. It has underperformed by 19.81% the S&P500.

Among 15 analysts covering Boston Beer Co (NYSE:SAM), 1 have Buy rating, 4 Sell and 10 Hold. Therefore 7% are positive. Boston Beer Co has $295 highest and $126.0 lowest target. $164.10’s average target is -12.41% below currents $187.35 stock price. Boston Beer Co had 53 analyst reports since July 28, 2015 according to SRatingsIntel. The firm has “Sell” rating by Cowen & Co given on Thursday, October 26. The stock has “Hold” rating by RBC Capital Markets on Friday, June 30. The stock has “Underperform” rating by CLSA on Tuesday, March 8. The rating was initiated by Credit Suisse on Friday, September 16 with “Underperform”. The rating was upgraded by Goldman Sachs to “Neutral” on Tuesday, October 20. The company was maintained on Tuesday, September 5 by Jefferies. The stock has “Hold” rating by Berenberg on Thursday, May 19. William Blair downgraded The Boston Beer Company, Inc. (NYSE:SAM) on Monday, January 9 to “Market Perform” rating. Jefferies maintained The Boston Beer Company, Inc. (NYSE:SAM) rating on Thursday, July 27. Jefferies has “Hold” rating and $14200 target. The firm has “Hold” rating by Jefferies given on Tuesday, October 10.

Investors sentiment decreased to 1.16 in Q3 2017. Its down 0.29, from 1.45 in 2017Q2. It worsened, as 22 investors sold MDRX shares while 72 reduced holdings. 44 funds opened positions while 65 raised stakes. 195.75 million shares or 0.88% less from 197.48 million shares in 2017Q2 were reported. Neuberger Berman Grp Inc holds 3.68 million shares or 0.07% of its portfolio. Numeric Invsts Limited Liability reported 666,800 shares. Moreover, Alliancebernstein Ltd Partnership has 0% invested in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) for 291,724 shares. Laurion Mngmt Limited Partnership reported 59,700 shares. Jefferies Lc owns 46,485 shares. Parametrica Management Limited owns 0.07% invested in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) for 11,800 shares. Commonwealth Of Pennsylvania Public School Empls Retrmt stated it has 26,347 shares or 0.01% of all its holdings. Gemmer Asset Mngmt Lc reported 242 shares stake. Fdx Advisors accumulated 16,927 shares. Geode Capital Management Limited Liability Company owns 1.62M shares. Moreover, First Interstate Fincl Bank has 0% invested in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) for 245 shares. The Minnesota-based Us Bancshares De has invested 0% in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX). Diversified holds 0.05% or 48,445 shares in its portfolio. Minnesota-based Ameriprise Fin has invested 0.01% in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX). Proshare Advsr Lc invested in 0% or 30,259 shares.

Since September 14, 2017, it had 0 insider purchases, and 6 insider sales for $974,699 activity. Poulton Richard J. had sold 15,000 shares worth $203,433 on Friday, September 15. The insider Black Paul sold 15,000 shares worth $202,800. $71,727 worth of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) shares were sold by Farley Brian.

Among 26 analysts covering Allscripts-Misys Healthcare (NASDAQ:MDRX), 12 have Buy rating, 1 Sell and 13 Hold. Therefore 46% are positive. Allscripts-Misys Healthcare had 56 analyst reports since August 5, 2015 according to SRatingsIntel. As per Friday, December 2, the company rating was initiated by Dougherty & Company. The firm has “Underweight” rating by Morgan Stanley given on Tuesday, December 13. The firm earned “Underweight” rating on Monday, August 7 by Morgan Stanley. The firm has “Buy” rating by RBC Capital Markets given on Sunday, October 29. Citigroup maintained Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) rating on Monday, August 7. Citigroup has “Neutral” rating and $14 target. The stock of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) has “Hold” rating given on Friday, July 21 by Piper Jaffray. The firm earned “Outperform” rating on Monday, March 27 by Wells Fargo. The stock of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) has “Buy” rating given on Thursday, October 6 by UBS. Topeka Capital Markets maintained the shares of MDRX in report on Tuesday, January 5 with “Hold” rating. The rating was maintained by Argus Research on Friday, January 22 with “Buy”.

Wellington Management Group Llp increased Inogen Inc (NASDAQ:INGN) stake by 10,847 shares to 112,907 valued at $10.74 million in 2017Q3. It also upped Old Second Bancorp Inc Ill (NASDAQ:OSBC) stake by 63,092 shares and now owns 1.92M shares. Rigel Pharmaceuticals Inc (NASDAQ:RIGL) was raised too.

Analysts await Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) to report earnings on February, 15. They expect $0.13 EPS, up 30.00% or $0.03 from last year’s $0.1 per share. MDRX’s profit will be $23.49 million for 29.18 P/E if the $0.13 EPS becomes a reality. After $0.12 actual EPS reported by Allscripts Healthcare Solutions, Inc. for the previous quarter, Wall Street now forecasts 8.33% EPS growth.